Trial · NCT04594369
Adverse events522
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 522
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | COVID-19 | Infections and infestations | Brensocatib 10 mg | 89 | 582 | |
| other | COVID-19 | Infections and infestations | Brensocatib 25 mg | 113 | 574 | |
| other | COVID-19 | Infections and infestations | Placebo | 83 | 563 | |
| other | Nasopharyngitis | Infections and infestations | Brensocatib 10 mg | 45 | 582 | |
| other | Nasopharyngitis | Infections and infestations | Brensocatib 25 mg | 36 | 574 | |
| other | Nasopharyngitis | Infections and infestations | Placebo | 43 | 563 | |
| other | Urinary tract infection | Infections and infestations | Brensocatib 10 mg | 27 | 582 | |
| other | Urinary tract infection | Infections and infestations | Brensocatib 25 mg | 30 | 574 | |
| other | Urinary tract infection | Infections and infestations | Placebo | 33 | 563 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Brensocatib 10 mg | 13 | 582 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Brensocatib 25 mg | 17 | 574 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Placebo | 35 | 563 | |
| other | Headache | Nervous system disorders | Brensocatib 10 mg | 39 | 582 | |
| other | Headache | Nervous system disorders | Brensocatib 25 mg | 49 | 574 | |
| other | Headache | Nervous system disorders | Placebo | 39 | 563 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Brensocatib 10 mg | 41 | 582 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Brensocatib 25 mg | 35 | 574 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Placebo | 36 | 563 | |
| serious | Anaemia | Blood and lymphatic system disorders | Brensocatib 10 mg | 0 | 582 | |
| serious | Anaemia | Blood and lymphatic system disorders | Brensocatib 25 mg | 0 | 574 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04594369/events